Cargando…

Lung-Directed Bacteriotherapy in Cystic Fibrosis: Could It Be an Option?

Due to the alarming spread of bacterial resistance to conventional drugs, the sole use of antibiotics to fight lung infections in cystic fibrosis (CF) is not resolutive, and novel strategies to replace or complement the use of antibiotics are highly desirable. Among these strategies, the use of prob...

Descripción completa

Detalles Bibliográficos
Autores principales:	Batoni, Giovanna, Maisetta, Giuseppantonio, Kaya, Esingül, Esin, Semih
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944708/ https://www.ncbi.nlm.nih.gov/pubmed/35326789 http://dx.doi.org/10.3390/antibiotics11030326

Ejemplares similares

Lactobacillus Probiotic Strains Differ in Their Ability to Adhere to Human Lung Epithelial Cells and to Prevent Adhesion of Clinical Isolates of Pseudomonas aeruginosa from Cystic Fibrosis Lung
por: Batoni, Giovanna, et al.
Publicado: (2023)

Antibacterial and Antibiofilm Effects of Lactobacilli Strains against Clinical Isolates of Pseudomonas aeruginosa under Conditions Relevant to Cystic Fibrosis
por: Batoni, Giovanna, et al.
Publicado: (2023)

Therapeutic Potential of Antimicrobial Peptides in Polymicrobial Biofilm-Associated Infections
por: Batoni, Giovanna, et al.
Publicado: (2021)

Planktonic and Biofilm-Associated Pseudomonas aeruginosa and Staphylococcus epidermidis Elicit Differential Human Peripheral Blood Cell Responses
por: Kaya, Esingül, et al.
Publicado: (2021)

Microbial Biofilms and Antibiofilm Agents 2.0
por: Batoni, Giovanna, et al.
Publicado: (2022)

In vitro Interaction of Pseudomonas aeruginosa Biofilms With Human Peripheral Blood Mononuclear Cells
por: Kaya, Esingül, et al.
Publicado: (2020)

Combination Strategies to Enhance the Efficacy of Antimicrobial Peptides against Bacterial Biofilms
por: Grassi, Lucia, et al.
Publicado: (2017)

Targeting Pseudomonas aeruginosa in the Sputum of Primary Ciliary Dyskinesia Patients with a Combinatorial Strategy Having Antibacterial and Anti-Virulence Potential
por: Maisetta, Giuseppantonio, et al.
Publicado: (2019)

The Semi-Synthetic Peptide Lin-SB056-1 in Combination with EDTA Exerts Strong Antimicrobial and Antibiofilm Activity against Pseudomonas aeruginosa in Conditions Mimicking Cystic Fibrosis Sputum
por: Maisetta, Giuseppantonio, et al.
Publicado: (2017)

The Anti-Microbial Peptide (Lin-SB056-1)(2)-K Reduces Pro-Inflammatory Cytokine Release through Interaction with Pseudomonas aeruginosa Lipopolysaccharide
por: Grassi, Lucia, et al.
Publicado: (2020)

Analogs of the Frog-skin Antimicrobial Peptide Temporin 1Tb Exhibit a Wider Spectrum of Activity and a Stronger Antibiofilm Potential as Compared to the Parental Peptide
por: Grassi, Lucia, et al.
Publicado: (2017)

Tannin profile, antioxidant properties, and antimicrobial activity of extracts from two Mediterranean species of parasitic plant Cytinus
por: Maisetta, Giuseppantonio, et al.
Publicado: (2019)

Editorial: Interspecies Interactions: Effects on Virulence and Antimicrobial Susceptibility of Bacterial and Fungal Pathogens
por: Maisetta, Giuseppantonio, et al.
Publicado: (2020)

Antibacterial, Antibiofilm, and Antiadhesive Properties of Different Quaternized Chitosan Derivatives
por: Piras, Anna Maria, et al.
Publicado: (2019)

Correction: Piras, A.M., et al. Antibacterial, Antibiofilm, and Antiadhesive Properties of Different Quaternized Chitosan Derivatives. Int. J. Mol. Sci. 2019, 20, 6297
por: Piras, Anna Maria, et al.
Publicado: (2021)

Generation of Persister Cells of Pseudomonas aeruginosa and Staphylococcus aureus by Chemical Treatment and Evaluation of Their Susceptibility to Membrane-Targeting Agents
por: Grassi, Lucia, et al.
Publicado: (2017)

Insights into the Antimicrobial Properties of Hepcidins: Advantages and Drawbacks as Potential Therapeutic Agents
por: Lombardi, Lisa, et al.
Publicado: (2015)

Chitosan nanoparticles loaded with the antimicrobial peptide temporin B exert a long-term antibacterial activity in vitro against clinical isolates of Staphylococcus epidermidis
por: Piras, Anna M., et al.
Publicado: (2015)

Antivirulence Properties of a Low-Molecular-Weight Quaternized Chitosan Derivative against Pseudomonas aeruginosa
por: Maisetta, Giuseppantonio, et al.
Publicado: (2021)

Combination of Two Kinds of Medicated Microparticles Based on Hyaluronic Acid or Chitosan for a Wound Healing Spray Patch
por: Fabiano, Angela, et al.
Publicado: (2021)

The Antimicrobial Peptide lin-SB056-1 and Its Dendrimeric Derivative Prevent Pseudomonas aeruginosa Biofilm Formation in Physiologically Relevant Models of Chronic Infections
por: Grassi, Lucia, et al.
Publicado: (2019)

Bacteriotherapy
Publicado: (1887)

Bacteriotherapy in Breast Cancer
por: Yaghoubi, Atieh, et al.
Publicado: (2019)

Bacteriotherapy for inflammatory bowel disease
por: Yoshimatsu, Yusuke, et al.
Publicado: (2021)

Editorial: Immune Response to Biofilms
por: Batoni, Giovanna, et al.
Publicado: (2021)

Betaine- and L-Carnitine-Based Ionic Liquids as Solubilising and Stabilising Agents for the Formulation of Antimicrobial Eye Drops Containing Diacerein
por: Grassiri, Brunella, et al.
Publicado: (2023)

Oxygen Sparing Effect of Bacteriotherapy in COVID-19
por: Ceccarelli, Giancarlo, et al.
Publicado: (2021)

Controlling skin microbiome as a new bacteriotherapy for inflammatory skin diseases
por: Ito, Yoshihiro, et al.
Publicado: (2022)

Bacteriotherapy for the treatment of intestinal dysbiosis caused by Clostridium difficile infection()
por: Adamu, Blessing O, et al.
Publicado: (2013)

Emerging applications of cancer bacteriotherapy towards treatment of pancreatic cancer
por: Henderson, Emily A., et al.
Publicado: (2023)

Current Treatment Options for Cystic Fibrosis-Related Liver Disease
por: Staufer, Katharina
Publicado: (2020)

Editorial: Advances in the discovery of natural molecules and their analogues against microbial infection-related biofilms
por: Quintieri, Laura, et al.
Publicado: (2022)

Oral Bacteriotherapy Reduces the Occurrence of Chronic Fatigue in COVID-19 Patients
por: Santinelli, Letizia, et al.
Publicado: (2022)

Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study
por: Ceccarelli, Giancarlo, et al.
Publicado: (2021)

Managing the Skin Microbiome as a New Bacteriotherapy for Inflammatory Atopic Dermatitis
por: Dewi, Dian Andriani Ratna, et al.
Publicado: (2023)

Chronic rhinosinusitis in cystic fibrosis: a review of therapeutic options
por: Krajewska, Joanna, et al.
Publicado: (2021)

Lung Microbiome in Cystic Fibrosis
por: Scialo, Filippo, et al.
Publicado: (2021)

Mucoadhesive probiotic backpacks with ROS nanoscavengers enhance the bacteriotherapy for inflammatory bowel diseases
por: Liu, Jun, et al.
Publicado: (2022)

Oral bacteriotherapy in children with recurrent respiratory infections: a real-life study
por: Tarantino, Vincenzo, et al.
Publicado: (2020)

Mycobacterium abscessus Infections in Cystic Fibrosis Individuals: A Review on Therapeutic Options
por: Recchia, Deborah, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r4tm2g02n7dg821ub89encmbtl